What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Weill Cornell Medicine, 1300 York Avenue, New York, NY (2026)

02/26/2026

It was a love for medicine that brought Dr. Nupoor Narula to the United States as a young child.

Her parents, a cardiologist and cardiac pathologist, moved their family from India to the U.S. to pursue career opportunities, laying the foundation for Dr. Narula and her brother to forge their own paths in medicine.

“My parents love their work, and their biggest advice was to find an interest and focus and pursue it vigorously,” says Dr. Narula, Weill Cornell Medicine and NewYork-Presbyterian Hospital cardiologist, director of the Women’s Heart Program and Cardiology Vascular Lab, and the Bruce B. Lerman Clinical Scholar. "I also learned from them the ability to pivot and be resilient. They moved from another country and established a beautiful life in the U.S."

Although Dr. Narula followed her parents into cardiology, they each have their own niches in the field, with Dr. Narula developing a passion for inherited aortic disorders. During medical school, she spent a year in Italy, where she followed individuals and families with inherited vascular conditions. "I cherished the opportunity to take care of families," she says.

The experience also crystallized her commitment to becoming a physician-scientist. She has honed her distinct niche and deepened her clinical and research expertise to include vascular imaging and vascular risk assessment in patients with genetic aortic disorders.

In addition to treating patients, she uniquely researches the risk of pregnancy-related aortic complications in women with genetic aortic diseases and the risk of vascular complications in individuals with aortic conditions more broadly. She also recently received her first National Institutes of Health (NIH) grant.

"I hope to answer many key questions that still exist in the aortic community. Most rewarding is seeing the direct impact of our high-level research on the care of our patients in real-time. It takes a team to move evidence-based care in the field forward. I'm grateful to my mentors, collaborators, and leaders in this field at Weill Cornell Medicine."

She is also grateful for another title in her life: mom. "Being a mother is my greatest joy and has personally made me a better doctor."

02/25/2026

Pancreatic cancer is called a “silent killer” for a reason. It often shows no symptoms until it’s already advanced, resulting in one of the lowest survival rates of all cancers. As Dr. Despina Siolas, an oncologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital, explains, “By the time many people are diagnosed with pancreatic cancer, the tumor is already too extensive for surgery.”

Currently, the first-line treatment for most patients is chemotherapy - a largely one-size-fits-all approach that is not effective for everyone. That is why Dr. Siolas and her team are focused on advancing pancreatic cancer care by working on personalized treatments and new therapies, so patients can have more options.

“Academic research at places like Weill Cornell is very important because we are allowed to do more cutting-edge studies that may transform patient care in bigger leaps and bounds,” Dr. Siolas says.

Her research focuses on KRAS, a gene mutated in 93% of pancreatic cancers. These mutations drive fast, uncontrolled tumor growth, but not all KRAS mutations act the same way.

Dr. Siolas and her colleagues found that certain mutations influence how aggressively it behaves and even how long patients live. For example, approximately 20% of patients have a KRAS G12R mutation, and they tend to live longer than those with other KRAS mutations.

By understanding these biological differences, researchers aim to design more precise treatments tailored to each patient’s cancer.

Dr. Siolas believes research is the key to progress: “We need to keep innovating and investing in research because that’s the only way we’re going to make meaningful progress for patients.”

This story originally appeared in Cornell University’s Research Matters.

Video: https://bit.ly/3N3R8uK

02/19/2026

Did you know that aneurysms can occur in the aorta?

An aortic aneurysm is a bulge in the body’s largest artery, which supplies blood and nutrients to the whole body. If the bulge gets too big, it can tear or burst and cause dangerous internal bleeding.

But there's hope. Dr. Nupoor Narula, a cardiologist and director of the Women’s Heart Program and Vascular Lab in the Division of Cardiology at Weill Cornell Medicine and NewYork-Presbyterian Hospital, received an NIH grant to advance research on better ways to understand these aneurysms.

“If detected timely, we can monitor aneurysms, institute appropriate medical therapy, and perform elective lifesaving procedures - aortic surgery - to prevent complications,” Dr. Narula said. “We need to be proactive rather than reactive.”

How can you protect yourself?
❤️ Ask about your family's heart history, especially any aortic problems.
❤️ Consider joining clinical studies; this is especially important for women.
❤️ If you're pregnant and have symptoms or a family history, talk to your doctor about heart imaging to catch problems early.

Click to learn more about the Marfan Syndrome and Aortopathy Program at Weill Cornell Medicine: https://bit.ly/3MkmYDo.

02/11/2026

Recent tuberculosis (TB) outbreaks in various parts of the U.S. have reminded us of TB's continued threat to human health. TB remains the world's leading infectious killer, causing more than 1 million deaths every year. It spreads through the air and can survive within the human body. Sometimes TB does not cause any illness, while in other cases it can progress to active disease, which becomes harder to treat when the bacteria cause extensive damage to the lungs or other organs.

TB is primarily a lung disease caused by a bacterium called Mycobacterium tuberculosis (Mtb). When someone with active TB coughs, speaks, or breathes, tiny droplets carrying the bacteria can linger in the air. Even as these particles dry out, TB uses built-in genetic defenses to survive long enough to infect the next person. Once inside the body, Mtb often settles in the lungs, where it may go on to cause active TB.

As these bacteria mutate, TB can become drug-resistant, making treatment longer, harder, and more expensive. TB also poses a heightened risk for people living with HIV or diabetes, who are more likely to develop active TB disease.

At Weill Cornell Medicine, Dr. Carl Nathan, a physician-scientist who studies immunology and microbiology, and Dr. Kyu Rhee, an infectious disease physician-scientist, lead NIH-funded research programs to better understand how TB is transmitted through the air and hope to uncover ways to reduce transmission and treat it more quickly. Their work has identified bacterial genes that help Mtb survive during airborne transmission.

Here's What We Know:
- Understanding how TB bacteria survive in the air may reveal new strategies to reduce transmission and help cure people sick with TB more quickly and safely.
- Continued investment in basic science and clinical research is key to improving TB care and outcomes worldwide.

Tuberculosis remains a complex global challenge today, but continued research is key to reducing transmission and improving treatment.

Check out our IMPACT Magazine to learn more. https://bit.ly/4rnrFer

02/10/2026

Victory Yinka-Banjo came to the United States from Nigeria with a dream to study with leading scientists and someday become one herself.

Now a first-year doctoral student in the Tri-Institutional Computational Biology and Medicine program at Weill Cornell Graduate School of Medical Sciences Victory is one step closer to achieving that goal while also inspiring other Black women.

"As an undergrad, there were sometimes spaces where I was the only one who looked like me," says Victory, who graduated from MIT in 2025. "At first, it made me self-conscious, but it has evolved into a source of strength. Believing in myself helps me show up well in those spaces and gives me a reason to lift up others like me."

Victory was drawn to chemistry and biology at an early age and later added computation and data analysis to the mix, thanks in part to her mother, a computer science professor in Nigeria.”

"My mom has definitely been my biggest mentor," she says. "All that she stands for and strives to be has influenced my goals."

From designing molecules for new medicines to using data to help predict patient outcomes, "thinking about how computation and biology can come together is so expansive," Victory says, noting that she is eager to learn as much as she can about the field before selecting a research focus.

"I’m very open-minded and what I care about is science that can be therapeutically relevant," she says. "I want to do science that matters to me and that I can put my full heart into."

She is also taking every opportunity to connect with other science minds.

"I really want to expand my network and meet people who I can learn from and who can learn from me," she says.

In addition to her own studies, Victory gives back to students in Nigeria through teaching computer coding classes and mentoring them in their own academic journey.

"One of my biggest motivations is thinking about students who share my dreams but don’t have the same privileges, like access to a funded scientific education in the U.S," she says. "I hope to create opportunities for them someday."

02/06/2026

Our Weill Cornell Medicine community comes together every year to raise awareness, support research and empower women to know their risk for heart disease.

Show your heart some love this year with these health tips: https://bit.ly/3LKNkhC

02/05/2026

Rich Meissner reflects on how quickly life changed over the past year and feels grateful to be breathing easier today.

A family vacation in summer 2024 turned traumatic after a serious car accident. While everyone was physically unharmed, the emotional shock triggered a major atrial fibrillation episode.

“I knew the intense stress from the accident brought this on,” Rich says. But the truth is, his heart had been working overtime for years.

Rich, 56, had a history of high blood pressure, weight issues, and heart disease in his family. In 2008, his doctor, Dr. Adam Cheriff, detected a concerning heart murmur. An ultrasound later confirmed hypertrophic cardiomyopathy (HCM), a genetic condition where the heart muscle thickens, making it difficult to pump blood.

Dizziness, fatigue, and shortness of breath had become part of Rich’s daily life, but he pushed through, especially during his decades as a Manhattan chef.

“I started walking a lot,” he says. “Over the course of the day, I could get in 12,000 steps or more.”

Still, after the accident, his care team knew something had changed.

After thoughtful conversations with our cardiologist, Dr. Diala Steitieh and his family, Rich made a big decision: septal myectomy, a surgery that removes part of the thickened heart wall to improve blood flow.

Cardiothoracic surgeon Dr. Leonard Girardi performed the procedure and the results were life‑changing.

Rich returned home in a week and was back at work two months later.

“My only regret is not getting the surgery done even sooner,” he says. “It’s major surgery, and I was nervous. But I’m so glad I did it.”

Rich is the executive chef at Eva’s Village, a New Jersey nonprofit helping those facing addiction, homelessness, and food insecurity. He chose this role to give back, slow down, and live with purpose.

“It can be so easy to let things slide,” Rich says. “But it’s so important.”

His story is a reminder: with the right care, the right team, and the right moment of courage, breathing easier is possible.

Read Rich's story: https://bit.ly/49Xu2NL

02/03/2026

Today we thank and celebrate our women physicians and the many ways they exemplify compassionate care, inspiring leadership and unwavering dedication.

Happy National Women Physicians Day!

01/28/2026

Autism is a complex condition, and it’s completely understandable that parents feel overwhelmed by all the conflicting information out there. Scientists have spent many years trying to better understand autism and its causes.

Here’s what we know: Decades of research show that autism doesn't have one single cause, but a combination of genetic and environmental factors contributes. Importantly, extensive research across millions of children has found no link between vaccines and autism.

The idea that vaccines cause autism came from a 1998 study that was later proven false and taken out of publication. Autism is often identified around the same time children receive routine vaccines because that's when developmental differences become visible, not because vaccines cause autism, a claim disproven by extensive studies.

It can feel like autism is becoming more common, but the rise in diagnoses is largely due to greater awareness, broader diagnostic criteria, and improved screening tools, not a sudden increase in autism itself.

With funding and time, scientists can continue uncovering new clues that will help build understanding and better lives for individuals and families living with autism.

All 17 childhood vaccines remain strongly recommended because they protect children from serious and preventable diseases.

01/27/2026

When it comes to exceptional patient care, Weill Cornell Medicine sets the standard. We're proud to announce that nearly 500 of our doctors have been named to the 2026 Castle Connolly Top Doctors.

Did your doctor make the list?

For more than 35 years, patients have relied on Castle Connolly as their go-to source for finding Top Doctors who deliver trusted and high-quality care. Each physician in their network has undergone a rigorous selection process, beginning with nominations from their peers and followed by a detailed review conducted by our dedicated research team. We’re here to ensure you have access to the best in healthcare, so you can focus on what truly matters: your health and well-being!

Full list: https://bit.ly/4rlAXrs

01/27/2026

Dr. Yesie Yoon's curiosity in psychiatry began with a special friend.

Dr. Yoon was 12 and adjusting to life in Australia, where her family had moved temporarily from South Korea for her father’s job.

At a suburban Melbourne playground, Dr. Yoon crossed paths with two sisters, and she learned they were adopted from Korea. One sister didn't talk much and was always crying. But within a year, Dr. Yoon noticed a gradual change in her new friend. She was calmer, and they could play games together.

“I asked my mom, ‘How is she getting better?’ And she said, ‘There is a kind of doctor who can help kids feel better.’ And that’s when I first heard about someone called a psychiatrist," says Dr. Yoon, now a Weill Cornell Medicine child and adolescent psychiatrist at NewYork-Presbyterian Hospital Westchester Behavioral Health Center.

While a medical student in South Korea, Dr. Yoon was passionate about child psychiatry and embraced an opportunity to come to New York City and study treatment for children who had been sexually abused.

Inspired by the physician training she saw, she began to dream of becoming a child psychiatrist in the U.S.

She and her husband, also a medical student at the time and now a neurologist, matched for residencies in Ohio, where they spent five years. They were also raising two children during that time.

"I was a very young parent while going through training. I feel like it has helped me be a mom who has insights into a child's difficulties, and it has helped me to understand and relate better with my patients’ families. I’m not in their situation, but I can understand the struggles," says Dr. Yoon.

A child's mental health is often fueled by many factors, including school environment and family relationships, so identifying effective solutions can be complex and challenging, she says.

"I try to focus on what I am doing today and the one patient and family sitting in front of me and believing that I can make a difference," says Dr. Yoon.

And she hasn't forgotten about the special friend who made a difference in her life. Today, she is a thriving artist in Australia.

"I cherish the relationship we had that made me the person I am today," Dr. Yoon says.

01/21/2026

RSV is the leading cause of infant hospitalizations in the U.S. with cases escalating quickly from mild cold symptoms to serious illness or even death. Fortunately, parents can protect their children from this virus and keep them safe.

Dr. Karen Acker explains why RSV prevention tools, such as the RSV vaccine for pregnant women or antibody products for infants, are key to protecting children during their most vulnerable period after birth.

Here's What We Know:
- Since maternal RSV vaccines and antibody products became widely available in 2023, infant hospitalizations in the U.S. have dropped by around 50%.
- With the maternal RSV vaccine, a mother passes her protective antibodies to the baby in the womb, providing early immunity during the critical first months of life. Alternatively, the antibody shot given to a newborn is also effective.
- Both clinical trials and research show that FDA-approved RSV vaccines and antibody products are safe and effective in reducing severe RSV illness, emergency room visits and hospitalizations.

If your child is feeling sick or if you have questions about RSV, please reach out to your pediatrician for guidance.

Weill Cornell Medicine

02/26/2026

02/25/2026

02/19/2026

02/11/2026

02/10/2026

02/06/2026

02/05/2026

02/03/2026

01/28/2026

01/27/2026

01/27/2026

01/21/2026

Address

Opening Hours

Website

Alerts

Shortcuts

Featured

Share

Category

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm